Nkarta, Inc. (NKTX)
NASDAQ
Market Cap
$420.69M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
8 of 809
Rank in Industry
6 of 445
Largest Insider Buys in Sector
NKTX Stock Price History Chart
NKTX Stock Performance
About Nkarta, Inc.
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Insider Activity of Nkarta, Inc.
Over the last 12 months, insiders at Nkarta, Inc. have bought $50M and sold $394,603 worth of Nkarta, Inc. stock.
On average, over the past 5 years, insiders at Nkarta, Inc. have bought $149.67M and sold $1.6M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. () — $750M. George Simeon (director) — $60M.
The last purchase of 3,000,000 shares for transaction amount of $30M was made by RA CAPITAL MANAGEMENT, L.P. () on 2024‑03‑27.
List of Insider Buy and Sell Transactions, Nkarta, Inc.
| 2024-06-18 | Sale | HASTINGS PAUL J | Chief Executive Officer | 1,770 0.0022% | $5.60 | $9,912 | +5.31% | |
| 2024-06-18 | Sale | Trager James | Chief Scientific Officer | 456 0.0006% | $5.60 | $2,554 | +5.31% | |
| 2024-06-18 | Sale | Shook David | Chief Medical Officer | 456 0.0006% | $5.60 | $2,554 | +5.31% | |
| 2024-06-18 | Sale | Hager Alicia J. | Chief Legal Officer | 727 0.0009% | $5.60 | $4,071 | +5.31% | |
| 2024-06-18 | Sale | Brandenberger Ralph | Chief Technical Officer | 229 0.0003% | $5.60 | $1,282 | +5.31% | |
| 2024-03-27 | RA CAPITAL MANAGEMENT, L.P. | 3M 5.4767% | $10.00 | $30M | -38.48% | |||
| 2024-03-27 | George Simeon | director | 2M 3.6511% | $10.00 | $20M | -38.48% | ||
| 2024-03-01 | Sale | Brandenberger Ralph | Chief Technical Officer | 8,367 0.0167% | $12.51 | $104,671 | -44.16% | |
| 2024-02-12 | Sale | Trager James | Chief Scientific Officer | 4,143 0.0088% | $12.00 | $49,716 | -32.18% | |
| 2024-01-16 | Sale | HASTINGS PAUL J | Chief Executive Officer | 9,697 0.02% | $8.74 | $84,752 | +0.63% | |
| 2024-01-16 | Sale | Trager James | Chief Scientific Officer | 4,560 0.0094% | $8.74 | $39,854 | +0.63% | |
| 2024-01-16 | Sale | Shook David | Chief Medical Officer | 3,552 0.0073% | $8.74 | $31,044 | +0.63% | |
| 2024-01-16 | Sale | Hager Alicia J. | Chief Legal Officer | 4,554 0.0094% | $8.74 | $39,802 | +0.63% | |
| 2024-01-16 | Sale | Brandenberger Ralph | Chief Technical Officer | 2,512 0.0052% | $8.74 | $21,955 | +0.63% | |
| 2023-08-21 | Sale | Shook David | Chief Medical Officer | 1,331 0.0027% | $1.83 | $2,436 | +252.75% | |
| 2023-06-20 | Sale | HASTINGS PAUL J | Chief Executive Officer | 1,704 0.0035% | $4.85 | $8,264 | -6.16% | |
| 2023-06-20 | Sale | Trager James | Chief Scientific Officer | 439 0.0009% | $4.85 | $2,129 | -6.16% | |
| 2023-06-20 | Sale | Mahmood Nadir | See Remarks | 526 0.0011% | $4.85 | $2,551 | -6.16% | |
| 2023-06-20 | Sale | Shook David | Chief Medical Officer | 439 0.0009% | $4.85 | $2,129 | -6.16% | |
| 2023-06-20 | Sale | Hager Alicia J. | Chief Legal Officer | 701 0.0014% | $4.85 | $3,400 | -6.16% |
Insider Historical Profitability
<0.0001%
| RA CAPITAL MANAGEMENT, L.P. | 10050818 15.9054% | $5.97 | 3 | 0 | <0.0001% | |
| George Simeon | 1548341 1.3585% | $5.97 | 2 | 0 | <0.0001% | |
| HASTINGS PAUL J | Chief Executive Officer | 240737 0.7958% | $5.97 | 0 | 8 | |
| Trager James | Chief Scientific Officer | 150959 0.3129% | $5.97 | 0 | 10 | |
| Shook David | Chief Medical Officer | 116524 0.2343% | $5.97 | 0 | 5 | |
| Hager Alicia J. | Chief Legal Officer | 107215 0.22% | $5.97 | 0 | 4 | |
| Brandenberger Ralph | Chief Technical Officer | 79743 0.1662% | $5.97 | 0 | 13 | |
| GLAXOSMITHKLINE PLC | 3150732 6.4206% | $5.97 | 1 | 0 | <0.0001% | |
| BASKETT FOREST | 10 percent owner | 2902115 5.914% | $5.97 | 1 | 0 | <0.0001% |
| MAKOWER JOSHUA | 10 percent owner | 2902115 5.914% | $5.97 | 1 | 0 | <0.0001% |
| SANDELL SCOTT D | 10 percent owner | 2902115 5.914% | $5.97 | 1 | 0 | <0.0001% |
| Sonsini Peter W. | 10 percent owner | 2902115 5.914% | $5.97 | 1 | 0 | <0.0001% |
| Makhzoumi Mohamad | 10 percent owner | 2902115 5.914% | $5.97 | 1 | 0 | <0.0001% |
| Florence Anthony A. Jr. | 10 percent owner | 2902115 5.914% | $5.97 | 1 | 0 | <0.0001% |
| New Enterprise Associates 15, L.P. | 10 percent owner | 2902115 5.914% | $5.97 | 1 | 0 | <0.0001% |
| Novo Holdings A/S | 10 percent owner | 2793865 5.6934% | $5.97 | 1 | 0 | <0.0001% |
| Flynn James E | director | 1209936 2.4656% | $5.97 | 1 | 0 | <0.0001% |
| Mahmood Nadir | See Remarks | 85776 0.1748% | $5.97 | 0 | 9 | |
| Rajangam Kanya | Chief Medical Officer | 0 0% | $5.97 | 0 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| RA Capital Management, L.P. | $116.8M | 15.33 | 10.81M | +38.44% | +$32.43M | 0.12 | |
| Boxer Capital, LLC | $60.62M | 7.96 | 5.61M | +289.4% | +$45.05M | 3.03 | |
| Deerfield Management | $56.15M | 7.37 | 5.19M | +52.77% | +$19.39M | 1.09 | |
| Adage Capital Partners Gp L L C | $41.08M | 5.39 | 3.8M | +10.14% | +$3.78M | 0.08 | |
| Samsara Biocapital Llc | $40.73M | 5.35 | 3.77M | +31.38% | +$9.73M | 6.35 | |
| Nea Management Company Llc | $38.58M | 5.06 | 3.57M | 0% | +$0 | 0.44 | |
| Sr One Capital Management Lp | $36.03M | 4.73 | 3.33M | +150% | +$21.62M | 9.9 | |
| Commodore Capital, LP | $34.21M | 4.49 | 3.17M | +15.93% | +$4.7M | 2.41 | |
| BlackRock | $30.54M | 4.01 | 2.83M | +8.71% | +$2.45M | <0.01 | |
| Ecor1 Capital Llc | $21.62M | 2.84 | 2M | New | +$21.62M | 0.55 | |
| The Vanguard Group | $21.26M | 2.79 | 1.97M | +26% | +$4.39M | <0.0001 | |
| T Rowe Price Investment Management Inc | $14.65M | 1.92 | 1.36M | +192.83% | +$9.65M | 0.01 | |
| Cormorant Asset Management Lp | $14.59M | 1.92 | 1.35M | New | +$14.59M | 0.69 | |
| Wasatch Advisors | $12.63M | 1.66 | 1.17M | -44.35% | -$10.07M | 0.07 | |
| Ameriprise Financial | $12.11M | 1.59 | 1.12M | +10,800.12% | +$12M | <0.01 | |
| Janus Henderson | $9.07M | 1.19 | 838,839 | New | +$9.07M | 0.01 | |
| Geode Capital Management | $8.81M | 1.16 | 814,408 | +24.58% | +$1.74M | <0.01 | |
| Renaissance Technologies | $8.81M | 1.16 | 814,872 | +23.88% | +$1.7M | 0.01 | |
| OrbiMed | $8.65M | 1.14 | 800,000 | New | +$8.65M | 0.18 | |
| State Street | $6.8M | 0.89 | 629,155 | +2.83% | +$187,077.87 | <0.0001 | |
| Woodline Partners LP | $6.76M | 0.89 | 625,129 | New | +$6.76M | 0.06 | |
| Tang Capital Management, LLC | $5.95M | 0.78 | 550,000 | 0% | +$0 | 0.02 | |
| Alyeska Investment Group L P | $5.81M | 0.76 | 537,580 | +19.27% | +$938,837.72 | 0.04 | |
| Citadel Advisors LLC | $4.56M | 0.6 | 422,234 | New | +$4.56M | <0.01 | |
| Schonfeld Group | $4.33M | 0.57 | 400,100 | New | +$4.33M | 0.03 | |
| JPMorgan Chase | $3.73M | 0.49 | 345,159 | -3.37% | -$130,303.75 | <0.0001 | |
| Northern Trust | $3.43M | 0.45 | 317,227 | -1.1% | -$38,072.82 | <0.01 | |
| Soleus Capital Management, L.P. | $3.24M | 0.43 | 300,000 | New | +$3.24M | 0.03 | |
| Parkman Healthcare Partners Llc | $2.72M | 0.36 | 252,028 | New | +$2.72M | 0.34 | |
| Two Sigma | $2.68M | 0.35 | 248,147 | +77.32% | +$1.17M | 0.01 | |
| Octagon Capital Advisors LP | $2.59M | 0.34 | 240,000 | New | +$2.59M | 0.34 | |
| Nuveen | $2.52M | 0.33 | 233,090 | +153.56% | +$1.53M | <0.01 | |
| Cibc World Markets Corp | $2.16M | 0.28 | 200,000 | New | +$2.16M | 0.01 | |
| CIBC World Markets | $2.16M | 0.28 | 200,000 | New | +$2.16M | 0.01 | |
| Marshall Wace | $2.01M | 0.26 | 185,869 | -25.85% | -$700,466.42 | <0.01 | |
| Morgan Stanley | $1.92M | 0.25 | 177,595 | -17.4% | -$404,488.59 | <0.0001 | |
| Bridgeway Capital Management | $1.83M | 0.24 | 169,467 | -55.34% | -$2.27M | 0.03 | |
| Wellington Management Company | $1.4M | 0.18 | 129,374 | New | +$1.4M | <0.0001 | |
| Walleye Capital | $1.34M | 0.18 | 124,119 | New | +$1.34M | <0.01 | |
| Jane Street Capital | $1.32M | 0.17 | 122,027 | -16.55% | -$261,645.27 | <0.01 | |
| Squarepoint Ops LLC | $1.05M | 0.14 | 97,196 | +165.26% | +$654,588.89 | <0.01 | |
| Dimensional Fund Advisors | $1.04M | 0.14 | 96,663 | +70.82% | +$433,221.55 | <0.0001 | |
| BNY Mellon | $1.03M | 0.14 | 95,550 | -9.84% | -$112,661.33 | <0.0001 | |
| Stifel | $1.02M | 0.13 | 93,934 | -54.68% | -$1.23M | <0.01 | |
| Charles Schwab | $966,717.00 | 0.13 | 89,428 | +29.4% | +$219,648.46 | <0.0001 | |
| Ubs Oconnor Llc | $864,800.00 | 0.11 | 80,000 | New | +$864,800.00 | 0.07 | |
| Susquehanna Fundamental Investments Llc | $788,027.00 | 0.1 | 72,898 | New | +$788,027.00 | 0.04 | |
| AllianceBernstein | $722,324.00 | 0.1 | 66,820 | 0% | +$0 | <0.0001 | |
| Fidelity Investments | $702,088.00 | 0.09 | 64,948 | -53.18% | -$797,399.79 | <0.0001 | |
| Goldman Sachs | $568,692.00 | 0.08 | 52,608 | -33.55% | -$287,113.36 | <0.0001 |